Status:
COMPLETED
Efficacy of Selegiline in Negative Symptoms of Schizophrenia
Lead Sponsor:
Tabriz University
Conditions:
Schizophrenia
Eligibility:
All Genders
20-65 years
Phase:
EARLY_PHASE1
Brief Summary
Antipsychotic drugs are effective in treating the positive symptoms of schizophrenia; however their efficacy in treating negative symptoms is limited. This study wants to evaluate efficacy of selegili...
Eligibility Criteria
Inclusion
- Patients with moderate to severe negative symptoms
- Patients with at least one year antipsychotic drug therapy, at the current dose \>= 1 month.
- No other psychotropic drugs during past month
Exclusion
- Severe major depressive disorder
- Substance abuse
- Severe positive symptoms of schizophrenia
- Treatment of MDD with antidepressant drugs during past month.
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
End Date :
September 1 2007
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00456976
Start Date
April 1 2007
End Date
September 1 2007
Last Update
July 23 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Razi university hospital
Tabriz, East Azerbaijan Province, Iran, 5167846184